V. Lakis, R.T. Lawlor, F. Newell, A.M. Patch, A. Mafficini, A. Sadanandam et al. DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association. Commun. Biol. 4(1), 155 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

J. Hallet, C.H. Law, M. Cukier, R. Saskin, N. Liu, S. Singh, Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer 121, 589–597 (2015)

Article  PubMed  Google Scholar 

I.D. Nagtegaal, R.D. Odze, D. Klimstra, V. Paradis, M. Rugge, P. Schirmacher et al. The 2019 WHO classification of tumours of the digestive system. Histopathology 76(2), 182–188 (2020)

Article  PubMed  Google Scholar 

G. Rindi, F. Inzani, Neuroendocrine neoplasm update: toward universal nomenclature. Endocr. Relat. Cancer 27(6), R211–R218 (2020)

Article  CAS  PubMed  Google Scholar 

O.C. Taskin, C.N. Clarke, M. Erkan, S. Tsai, D.B. Evans, V. Adsay, Pancreatic neuroendocrine neoplasms: current state and ongoing controversies on terminology, classification and prognostication. J. Gastrointest. Oncol. 11(3), 548–558 (2020)

Article  PubMed  PubMed Central  Google Scholar 

M.L. Sulciner, T.E. Clancy, Surgical management of pancreatic neuroendocrine tumors. Cancers 15(7), 2006 (2023)

Article  CAS  PubMed  PubMed Central  Google Scholar 

L. Lee, T. Ito, R.T. Jensen, Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies. Expert Rev. Anticancer Ther. 19(12), 1029–1050 (2019)

Article  CAS  PubMed  PubMed Central  Google Scholar 

Z.Y. Ma, Y.F. Gong, H.K. Zhuang, Z.X. Zhou, S.Z. Huang, Y.P. Zou et al. Pancreatic neuroendocrine tumors: a review of serum biomarkers, staging, and management. World J. Gastroenterol. 26(19), 2305–2322 (2020)

Article  CAS  PubMed  PubMed Central  Google Scholar 

L. Quan, Y. Liu, W. Cui, X. Wang, W. Zhang, Z. Wang et al. The associations between serum high-density lipoprotein cholesterol levels and malignant behavior in pancreatic neuroendocrine neoplasms. Lipids Health Dis. 21(1), 58 (2022)

Article  CAS  PubMed  PubMed Central  Google Scholar 

X. Zhuge, Y. Wang, X. Chen, C. Guo, Diabetes in patients with pancreatic neuroendocrine neoplasms. Front. Endocrinol. 11, 615082 (2020)

Article  Google Scholar 

V. Rosiek, A. Bocian-Jastrzębska, B. Kos-Kudła, Selected serum biomarkers (leptin, chromogranin A, CA19-9, CEA) in patients with pancreatic neuroendocrine neoplasm and associations with metabolic syndrome. Cancers 15(8), 2348 (2023)

Article  CAS  PubMed  PubMed Central  Google Scholar 

B. Kos-Kudła, W. Foltyn, A. Malczewska, T. Bednarczuk, M. Bolanowski, M. Borowska, et al., Update of the diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol. Pol. 73(3), 387–454 (2022).

Article  PubMed  Google Scholar 

R. Modica, E. Benevento, A. Liccardi, G. Cannavale, R. Minotta, G. DI Iasi, et al. Recent advances and future challenges in the diagnosis of neuroendocrineneoplasms. Minerva Endocrinol. (2024) https://doi.org/10.23736/S2724-6507.23.04140-4

R. Modica, A. Liccardi, R. Minotta, G. Cannavale, E. Benevento, A. Colao, Therapeutic strategies for patients with neuroendocrine neoplasms: current perspectives. Expert Rev. Endocrinol. Metab. 17(5), 389–403 (2022)

Article  CAS  PubMed  Google Scholar 

F. Luo, K.M. Zeng, J.X. Cao, T. Zhou, S.X. Lin, W.J. Ma et al. Predictive value of a reduction in the level of high-density lipoprotein-cholesterol in patients with non-small-cell lung cancer undergoing radical resection and adjuvant chemotherapy: a retrospective observational study. Lipids Health Dis. 20(1), 109 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

J. Wang, W.J. Wang, L. Zhai, D.F. Zhang, Association of cholesterol with risk of pancreatic cancer: a meta-analysis. World J. Gastroenterol. 21(12), 3711–3719 (2015)

Article  CAS  PubMed  PubMed Central  Google Scholar 

S. Ganjali, M. Banach, M. Pirro, Z. Fras, A. Sahebkar, HDL and cancer - causality still needs to be confirmed? Update 2020. Semin. Cancer Biol. 73, 169–177 (2021)

Article  CAS  PubMed  Google Scholar 

D. Gu, B. Xue, G. Zhu, Y. Xu, L. Yan, Q. Tang et al. Serum lipid level in evaluating chinese pancreatic neuroendocrine neoplasms: a retrospective study. Exp. Clin. Endocrinol. Diabetes 132(2), 98–106 (2024)

Article  PubMed  PubMed Central  Google Scholar 

C.D.L. Johannesen, M.B. Mortensen, A. Langsted, B.G. Nordestgaard, Apolipoprotein B and non-HDL cholesterol better reflect residual risk than LDL cholesterol in statin-treated patients. J. Am. Coll. Cardiol. 77(11), 1439–1450 (2021)

Article  CAS  PubMed  Google Scholar 

Y. Sunami, A. Rebelo, J. Kleeff, Lipid metabolism and lipid droplets in pancreatic cancer and stellate cells. Cancers 10(1), 3 (2017)

Article  PubMed  PubMed Central  Google Scholar 

M.B.S. Lopes, The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol. 134(4), 521–535 (2017)

Article  CAS  PubMed  Google Scholar 

G. Centonze, P. Maisonneuve, N. Prinzi, S. Pusceddu, L. Albarello, E. Pisa et al. Prognostic factors across poorly differentiated neuroendocrine neoplasms: a pooled analysis. Neuroendocrinology 113(4), 457–469 (2023)

Article  CAS  PubMed  Google Scholar 

H. Sorbye, S. Welin, S.W. Langer, L.W. Vestermark, N. Holt, P. Osterlund et al. Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study. Ann Oncol. 24(1), 152–160 (2013)

Article  CAS  PubMed  Google Scholar 

M. Milione, P. Maisonneuve, F. Grillo, A. Mangogna, G. Centonze, N. Prinzi et al. Ki-67 index of 55% distinguishes two groups of bronchopulmonary pure and composite large cell neuroendocrine carcinomas with distinct prognosis. Neuroendocrinology 111(5), 475–489 (2021)

Article  CAS  PubMed  Google Scholar 

R. Sun, H. Xu, F. Liu, B. Zhou, M. Li, X. Sun, Unveiling the intricate causal nexus between pancreatic cancer and peripheral metabolites through a comprehensive bidirectional two-sample Mendelian randomization analysis. Front. Mol. Biosci. 10, 1279157 (2023)

Article  CAS  PubMed  PubMed Central  Google Scholar 

X. Yin, R. Xu, J. Song, R. Ruze, Y. Chen, C. Wang et al. Lipid metabolism in pancreatic cancer: emerging roles and potential targets. Cancer Commun. 42(12), 1234–1256 (2022)

Article  Google Scholar 

N. Elebo, J. Omoshoro-Jones, P.N. Fru, J. Devar, C. De Wet van Zyl et al. Serum metabolomic and lipoprotein profiling of pancreatic ductal adenocarcinoma patients of african ancestry. Metabolites 11(10), 663 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

Y.Y. Jung, J.H. Ko, J.Y. Um, A. Chinnathambi, S.A. Alharbi, G. Sethi et al. LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway. J. Cell. Physiol. 236(7), 5253–5264 (2021)

Article  CAS  PubMed  Google Scholar 

R. Modica, A. La Salvia, A. Liccardi, A. Cozzolino, A. Di Sarno, F. Russo, et al. Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons. Endocrine (2024) https://doi.org/10.1007/s12020-024-03767-7

R. Modica, A. La Salvia, A. Liccardi, G. Cannavale, R. Minotta, E. Benevento et al. Lipid metabolism and homeostasis in patients with neuroendocrineneoplasms: from risk factor to potential therapeutic target. Metabolites 12(11), 1057 (2022)

Article  CAS  PubMed  PubMed Central  Google Scholar 

R. Bettini, L. Boninsegna, W. Mantovani, P. Capelli, C. Bassi, P. Pederzoli et al. Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours. Ann. Oncol. 19(5), 903–908 (2008)